CN102475798A - Cold-damaging medicine - Google Patents
Cold-damaging medicine Download PDFInfo
- Publication number
- CN102475798A CN102475798A CN2010105601976A CN201010560197A CN102475798A CN 102475798 A CN102475798 A CN 102475798A CN 2010105601976 A CN2010105601976 A CN 2010105601976A CN 201010560197 A CN201010560197 A CN 201010560197A CN 102475798 A CN102475798 A CN 102475798A
- Authority
- CN
- China
- Prior art keywords
- medicine
- chinese
- western
- traditional chinese
- western medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 208000037386 Typhoid Diseases 0.000 claims abstract description 25
- 201000008297 typhoid fever Diseases 0.000 claims abstract description 25
- 208000004429 Bacillary Dysentery Diseases 0.000 claims abstract description 7
- 206010017915 Gastroenteritis shigella Diseases 0.000 claims abstract description 7
- 201000005113 shigellosis Diseases 0.000 claims abstract description 7
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims abstract description 6
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229960001259 diclofenac Drugs 0.000 claims abstract description 3
- 229960001625 furazolidone Drugs 0.000 claims abstract description 3
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 claims abstract description 3
- -1 gastroparen Chemical compound 0.000 claims abstract description 3
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229960004503 metoclopramide Drugs 0.000 claims abstract description 3
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229960001180 norfloxacin Drugs 0.000 claims abstract description 3
- 229960005489 paracetamol Drugs 0.000 claims abstract description 3
- 229910052623 talc Inorganic materials 0.000 claims abstract description 3
- 239000000454 talc Substances 0.000 claims abstract description 3
- 206010033971 Paratyphoid fever Diseases 0.000 claims description 8
- 239000002547 new drug Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 2
- 235000012222 talc Nutrition 0.000 claims description 2
- 206010017894 Gastroenteritis bacillus Diseases 0.000 claims 1
- 239000006187 pill Substances 0.000 abstract description 11
- 208000005577 Gastroenteritis Diseases 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 5
- 239000002552 dosage form Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 230000007170 pathology Effects 0.000 abstract description 2
- 208000009084 Cold Injury Diseases 0.000 abstract 2
- 229940126678 chinese medicines Drugs 0.000 abstract 2
- 230000002595 cold damage Effects 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000003826 Artemisia Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 240000002505 Pogostemon cablin Species 0.000 abstract 1
- 235000011751 Pogostemon cablin Nutrition 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000002594 Solanum nigrum Nutrition 0.000 abstract 1
- 240000002307 Solanum ptychanthum Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 244000030166 artemisia Species 0.000 abstract 1
- 235000009052 artemisia Nutrition 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241001467018 Typhis Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001120 cytoprotective effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The cold injury medicine is a modern Chinese and western medicine combined specific new medicine for treating infectious cold injury diseases (including paratyphoid, gastroenteritis and bacillary dysentery), and adopts the technical scheme for solving the technical problems that: according to the etiology and pathology and clinical symptoms of typhoid fever, the theory of treating both manifestation and root cause of disease and combining traditional Chinese medicine and western medicine is adopted and the traditional Chinese medicine and western medicine are combined. The specific formula is as follows: the traditional Chinese medicine pill is prepared by crushing 19 Chinese and western medicines including radix bupleuri, hawthorn, patchouli, subprostrate sophora, honeysuckle stem, scutellaria baicalensis, artemisia capillaries, black nightshade, radish seed, talc, mangnolia officinalis, eupatorium, dried orange peel, norfloxacin, diclofenac, acetaminophen, gastroparen, metoclopramide and furazolidone in the production process, not only preserves the original medicinal effective components of the traditional Chinese medicine pill dosage form and the original Chinese medicines, but also embodies the new technical characteristics of the combination theory of the traditional Chinese medicine and the western medicine combining the typhoid fever medicine name with the pathogenic and pathological causes and clinical effects of the typhoid fever and the modern mechanical pill.
Description
Technical field: traditional Chinese medical science tradition oral medicine pill is a pure Chinese medicinal preparation; The typhoid fever medicine is the revolution of traditional Chinese medical science tradition pill production technology; Be adopt the combination of Chinese and Western medicine and the production of Chinese medicine and western medicine compatibility, both kept the dosage form and the drug effect of the traditional oral medicine pill of the traditional Chinese medical science; Embodied the bonded characteristic of Chinese and western medicine advantage again, clinical efficacy is superior to commercially available Chinese and Western commercially available medicine, is the specially good effect new drug of the modern infectiousness typhoid of treatment (comprising paratyphoid fever, gastroenteritis, bacillary dysentery).
Background technology: at present; Known typhoid (comprising typhoid fever, paratyphoid fever, gastroenteritis, bacillary dysentery) is the infectious disease that takes place by behind the bacterial infection human bodies such as Bacillus typhi, Salmonella paratyphi, escherichia coli, dysentery bacterium; What adopt both at home and abroad is such ketone, macrolide antibiotics treatment of penicillin, cephalo, pioneer, Kui; But how above-mentioned antibacterial to common antibiotics drug resistance, no matter be oral or the intravenously administrable clinical efficacy all not good.This typhoid fever medicine adopts theory of integrated Chinese and western medicine and Chinese medicine and western medicine compatibility, has effectively destroyed self cytoprotective of above-mentioned antibacterial and loses drug resistance.Chinese medicine and western medicine compatibility in the typhoid fever medicine can improve the lethality of medicine to antibacterial in addition, simultaneously compatibility the medicine of elimination typhoid (comprising typhoid fever, paratyphoid fever, gastroenteritis, bacillary dysentery) clinical symptoms, played antibacterial and the comprehensive function of eliminating clinical symptoms.
The typhoid fever medicine adopts theory of integrated Chinese and western medicine and Chinese medicine and western medicine compatibility; Selecting the Chinese herbal medicine and the biochemical medicine of anti-Bacillus typhi (comprising bacillus such as paratyphoid fever, enteritis, dysentery, large intestine) for use is principal agent; Clinical symptoms such as the rapid alleviating patient heating of the Chinese herbal medicine of the heat clearing away of compatibility antiinflammatory, damp-clearing pain-relieving, stomach function regulating emesis, relieving distension and biochemical medicine, dizziness, general pain, abdominal distention, weak, n or V, diarrhoea have played the comprehensive function of treating both the principal and secondary aspects of a disease.The pharmaceutical technology of typhoid fever medicine adopts the primary Chinese herbal medicine of traditional Chinese medical science tradition to pulverize and modern mechanical pill technology, and the pill dosage form still keeps traditional Chinese medical science traditional drugs pill-type drug effect then to embody the modern new drug characteristic of the combination of Chinese and Western medicine.
Summary of the invention: the typhoid fever medicine solves the technical scheme that its technical problem adopted and is: according to typhoid (comprising typhoid fever, paratyphoid fever, gastroenteritis, bacillary dysentery) is by behind the bacterial infection human bodies such as Bacillus typhi, Salmonella paratyphi, escherichia coli, dysentery bacterium, a series of immune inflammation reactions that the excretory detoxifying function of antibacterial produces in the human immune system.Adopting the antimicrobial biochemical medicine of Chinese herbal medicine compatibility with bacillus such as anti-typhoid fever, paratyphoid fever, dysentery, large intestines in theory at prescription is principal agent; The Chinese herbal medicine of compatibility antiinflammatory, analgesic, pain relieving, emesis, dehumidifying, removing dampness, dampness removing and biochemical medicine are eliminated the patients clinical symptom again.Concrete prescription is: Radix Bupleuri, Fructus Crataegi, Herba Pogostemonis, Radix Sophorae Tonkinensis, Caulis Lonicerae, Radix Scutellariae, Herba Artemisiae Scopariae, Herba Solani Nigri, Semen Raphani, Talcum, Cortex Magnoliae Officinalis, Herba Eupatorii, Pericarpium Citri Reticulatae, norfloxacin, diclofenac, acetaminophen, gastropine, metoclopramide, furazolidone amount to 19 kinds of Chinese medicine and western medicine and form; Adopt original Chinese herbal medicine to pulverize pill in process of production; Both preserve the primary effective ingredient of Chinese herbal medicine and traditional Chinese medical science tradition oral medicine pill dosage form, embodied the theory of integrated Chinese and western medicine that typhoid fever medicine medicine name combines with typhoid (comprising typhoid fever, paratyphoid fever, gastroenteritis, bacillary dysentery) etiology and pathology and clinical efficacy and the new technical feature of modernized mechanical pill again.
Clinical practice divides pack to be plastic bag by the 5 gram/bag packing of adult's common dose.Concrete consumption is: oral 1 bag of adult's common dose in 13-71 year 1 time, 3 times on the 1st; Old people more than 71 years old and the children's dosage below 13 years old cut down according to the circumstance.
The specific embodiment: typhoid fever medicine medicine name belongs to the inventor with the prescription title to patent; The inventor transfers typhoid fever medicine medicine name and prescription right of use patent within Chinese territory and overseas Chinese medical institutions and pharmaceutical producing enterprise, to support the development of domestic and international Chinese medicine.
Claims (2)
- One kind the treatment modern infectiousness typhoid (comprising paratyphoid fever, bacillary gastroenteritis, bacillary dysentery) combination of Chinese and Western medicine specially good effect new drug.
- 2. technical characterictic is the unique formula of typhoid fever medicine; Concrete prescription is: Radix Bupleuri, Fructus Crataegi, Herba Pogostemonis, Radix Sophorae Tonkinensis, Caulis Lonicerae, Radix Scutellariae, Herba Artemisiae Scopariae, Herba Solani Nigri, Semen Raphani, Talcum, Cortex Magnoliae Officinalis, Herba Eupatorii, Pericarpium Citri Reticulatae, norfloxacin, diclofenac, acetaminophen, gastropine, metoclopramide, furazolidone amount to 19 kinds of Chinese medicine and western medicine and form, and are the modern new drug of the combination of Chinese and Western medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105601976A CN102475798A (en) | 2010-11-23 | 2010-11-23 | Cold-damaging medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105601976A CN102475798A (en) | 2010-11-23 | 2010-11-23 | Cold-damaging medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102475798A true CN102475798A (en) | 2012-05-30 |
Family
ID=46088656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105601976A Pending CN102475798A (en) | 2010-11-23 | 2010-11-23 | Cold-damaging medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102475798A (en) |
-
2010
- 2010-11-23 CN CN2010105601976A patent/CN102475798A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104173937A (en) | Traditional Chinese medicine composition for dispersing stagnated liver qi for promoting bile flow and applications thereof | |
| CN104013756A (en) | Traditional Chinese medicine composition for preventing and treating diarrhea and application of traditional Chinese medicine composition | |
| CN101897879B (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN101229290A (en) | Chinese traditional medicine compounds for treating common cold and throat irritation, and preparing method thereof | |
| CN101966295A (en) | Medicament for treating chronic amygdalitis | |
| CN1150927C (en) | Stomatopathy and throat disease treating health care medicine and its production process | |
| CN101884663A (en) | Traditional Chinese medicine for treating cold and parotitis | |
| CN100998820A (en) | Orall Chinese medicine for treating damp-evil type cold | |
| CN102631450A (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
| CN102018874A (en) | Traditional Chinese medicine preparation for treating swelling | |
| CN102210769A (en) | Chinese medicinal composition for treating prostatitis | |
| CN102475798A (en) | Cold-damaging medicine | |
| CN101703711A (en) | Chinese medicinal preparation for treating septicemia | |
| CN1160102C (en) | Chinese medicine for curing female chronic inflammation | |
| CN105031225A (en) | Traditional Chinese medicine preparation for treating diabetes | |
| CN103638440A (en) | Traditional Chinese medicine for treating nonbacterial prostatitis | |
| CN103006950A (en) | Traditional Chinese medicine for treating pharyngolaryngitis and preparation process thereof | |
| CN101569681A (en) | Traditional Chinese medicine for treating urinary infection | |
| CN100415254C (en) | Anti-inflammatory and heat-relieving Chinese-herb preparation | |
| CN102908446A (en) | Traditional Chinese medicine preparation used for controlling severe acute pancreatitis and acute lung injury complications | |
| CN101693057A (en) | Traditional Chinese medicine preparation for treating chronic pelvic inflammatory disease | |
| CN101856484A (en) | Chinese medicament for treating acute gastroenteritis | |
| CN101085263A (en) | Traditional Chinese medicine decoction for treating urinary tract infection | |
| CN105125880A (en) | Traditional Chinese medicine for treating chronic tonsillitis | |
| CN101444497B (en) | Salvia miltiorrhiza danshinolic acid A and the application of a medicine composition containing salvia miltiorrhiza danshinolic acid A |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120530 |